1,2-dipalmitoylphosphatidylcholine has been researched along with leucine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, S; Inoue, T; Lee, S; Morikawa, M; Sugihara, G; Takiguchi, H; Yoshitomi, H | 1 |
| de Kruijff, B; Ganchev, DN; Killian, JA; Rijkers, DT; Snel, MM | 1 |
| Assi, F; Herbig, ME; Merkle, HP; Textor, M | 1 |
| Jiang, S; Liu, D; Pan, WS; Shi, Y; Wang, XB; Wang, YN; Xi, RG; Yang, XB | 1 |
| Hianik, T; Holúbeková, A; Melicherčík, M; Urban, J | 1 |
| Fattal, E; Ghermani, N; Guiblin, N; Pham, DD; Tsapis, N | 1 |
| Das, SC; Eedara, BB; Tucker, IG | 1 |
| Chen, L; Fan, R; Jia, L; Liu, Z; Luo, SZ; Yu, C; Yuan, Y; Zhang, Q; Zhou, XR | 1 |
| Akrivou, M; Bouropoulos, N; Eleftheriadis, GK; Fatouros, DG; Tsibouklis, J; Vizirianakis, IS | 1 |
| Cavallaro, A; Das, SC; Doyle, C; Eedara, BB; Rangnekar, B | 1 |
| Bahrainian, S; Gilani, K; Gilani, Z; Mirmoeini, MS | 1 |
11 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and leucine
| Article | Year |
|---|---|
Homooligopeptides composed of hydrophobic amino acid residues interact in a specific manner by taking alpha-helix or beta-structure toward lipid bilayers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Alanine; Amino Acid Sequence; Circular Dichroism; Leucine; Lipid Bilayers; Micelles; Molecular Sequence Data; Oligopeptides; Phenylalanine; Protein Conformation; Protein Structure, Secondary; Sodium Dodecyl Sulfate; Solvents; Thermodynamics; Trifluoroethanol; Valine | 1995 |
Strength of integration of transmembrane alpha-helical peptides in lipid bilayers as determined by atomic force spectroscopy.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Alanine; Leucine; Lipid Bilayers; Membrane Proteins; Membranes; Microscopy, Atomic Force; Models, Chemical; Peptides; Phosphatidylcholines; Protein Structure, Secondary; Protein Structure, Tertiary; Tryptophan; Water | 2004 |
The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Calcitonin; Cell Membrane; Cell Membrane Permeability; Cell Physiological Phenomena; Cytosol; Endocytosis; Fluorescence Polarization; Gels; Humans; Leucine; Lipid Bilayers; Models, Biological; Murinae; Peptides; Phosphatidylcholines; Phospholipids; Point Mutation; Time Factors; Tryptophan | 2006 |
Optimization and characterization of dry powder of fanhuncaoin for inhalation based on selection of excipients.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Anti-Inflammatory Agents; Calorimetry, Differential Scanning; Chitosan; Drugs, Chinese Herbal; Dry Powder Inhalers; Excipients; Leucine; Microscopy, Electron, Scanning; Oligosaccharides; Particle Size; Powders; Senecio | 2011 |
Effect of the aminoacid composition of model α-helical peptides on the physical properties of lipid bilayers and peptide conformation: a molecular dynamics simulation.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Dimyristoylphosphatidylcholine; Leucine; Lipid Bilayers; Lysine; Membrane Proteins; Molecular Dynamics Simulation; Peptides; Protein Conformation | 2013 |
Formulation of pyrazinamide-loaded large porous particles for the pulmonary route: avoiding crystal growth using excipients.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Antitubercular Agents; Bicarbonates; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Excipients; Hyaluronic Acid; Leucine; Particle Size; Porosity; Powder Diffraction; Pyrazinamide; X-Ray Diffraction | 2013 |
Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Desiccation; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Leucine; Lung; Nanoparticles; Particle Size; Phosphatidylethanolamines; Phospholipids; Polyethylene Glycols; Powders; Pyrazinamide; Tuberculosis | 2016 |
Isoleucine/leucine residues at "a" and "d" positions of a heptad repeat sequence are crucial for the cytolytic activity of a short anticancer lytic peptide.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Alanine; Amino Acid Sequence; Amino Acid Substitution; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Cell Survival; Cholesterol; HEK293 Cells; HeLa Cells; Humans; Isoleucine; L-Lactate Dehydrogenase; Leucine; Liposomes; Peptides; Phosphatidylserines; Protein Engineering; Protein Structure, Secondary; Static Electricity; Structure-Activity Relationship | 2017 |
Polymer-Lipid Microparticles for Pulmonary Delivery.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Budesonide; Cell Line, Tumor; Chitosan; Drug Carriers; Drug Compounding; Drug Liberation; Excipients; Female; Humans; Lactose; Leucine; Male; Mucus; Particle Size; Polyvinyl Alcohol; Pulmonary Surfactants | 2018 |
The influence of surface active l-leucine and 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) in the improvement of aerosolization of pyrazinamide and moxifloxacin co-spray dried powders.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Aerosols; Antitubercular Agents; Chemistry, Pharmaceutical; Desiccation; Excipients; Fluoroquinolones; Leucine; Moxifloxacin; Particle Size; Powders; Pyrazinamide | 2018 |
Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Administration, Inhalation; Aerosols; Dry Powder Inhalers; Leucine; Levodopa; Particle Size; Powders; Spray Drying | 2021 |